Developing tests to detect and identify infectious agents in humans
Task Area A: NIAID Preclinical Services for AMR Diagnostics Development
This study is working on better tests to quickly and accurately find harmful bacteria that don't respond to antibiotics, so doctors can give patients the right treatment and help them get better faster.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Midwest Research Institute NIH-funded |
| Lab location | 1 site (Kansas City, United States) |
| Project ID | NIH-10913853 on NIH RePORTER |
What this research studies
This research focuses on creating and improving diagnostic tests that can accurately detect and identify infectious agents, particularly bacteria that are resistant to antibiotics. The project aims to support the development of innovative assays and platforms that can characterize these pathogens effectively. By enhancing diagnostic capabilities, the research seeks to provide healthcare professionals with better tools to manage and treat infections caused by resistant bacteria. Patients may benefit from more accurate and timely diagnoses, leading to improved treatment outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from infections caused by antibiotic-resistant bacteria.
Not a fit: Patients with infections caused by non-bacterial pathogens or those who do not have antibiotic-resistant infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective diagnostic tests for bacterial infections, improving patient care and treatment options.
How similar studies have performed: Other research has shown success in developing diagnostic tests for infectious agents, indicating that this approach has potential for impactful outcomes.
Where this research is happening
Kansas City, United States
- Midwest Research Institute — Kansas City, United States (Active)
Researchers
- Principal investigator: Girard, Yvette — Midwest Research Institute
- Study coordinator: Girard, Yvette
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.